← Leaderboards
Vincent Duong
Yale University
$58,827
Attributed
$58,827
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $33.2K · FY2019–20$50K$37.5K$25K$12.5K$0
'19
'20
Funding mix
By agency
NIH$58,827 · 1
By mechanism
F31$58,827 · 1
Top collaborators
No co-investigators on record.
Most similar at Yale University
Same institution · by research overlap
- Yung-Chi Cheng$16,454,542
- Karen S Anderson$26,797,421
- William Jorgensen$15,848,158
- Elinore F. McCance-Katz$13,032,111
- Manisha Juthani-Mehta$4,179,365
Others in their field
Other Emerging Leaders on “Affect”
- Chanza Baytop · Westat, Inc.$271,217,917
- Leonard Freedman · Leidos Biomedical Research, Inc.$62,378,387
- Jennifer Marie Suga · Kaiser Foundation Research Institute$29,218,159
- Lynn Briscoe · Leidos Biomedical Research, Inc.$27,788,199
- George Robert Painter · University Of Alabama At Birmingham$27,619,145
- Jessica Brooke Langbaum · Banner Health$22,633,312
Research focus
AffectAntiviral AgentsAntiviral TherapyBaseBindingBiochemicalBiochemistryBypassCardiotoxicityCell LineCellsCellular AssayClinicCombined Modality TherapyComplexCompliance BehaviorCrystallizationDna Polymerase GammaDrug DesignDrug DevelopmentEpithelial CellsExperimental StudyFoundationsAdverse Drug Effect
Grant awards (2)
Tenofovir inhibition of human mitochondrial polymerase PrimPol and mechanisms of antiviral therapy-driven nephrotoxicity$25,601
F31 · FY2020 · AI · contact PI
Tenofovir inhibition of human mitochondrial polymerase PrimPol and mechanisms of antiviral therapy-driven nephrotoxicity$33,226
F31 · FY2019 · AI · contact PI